Rights statement: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Accepted author manuscript, 73.5 KB, Word document
Available under license: CC BY: Creative Commons Attribution 4.0 International License
Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Cochrane corner
T2 - interventions for the management of malignant pleural effusions
AU - Clive, Amelia
AU - Bhatnagar, Rahul
AU - Preston, Nancy Jean
AU - Maskell, Nick
AU - Jones, Hayley E.
N1 - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
PY - 2016/10/31
Y1 - 2016/10/31
N2 - Optimal management of symptomatic malignant pleural effusions remains an important issue as it affects a significant number of patients each year internationally. The overall survival remains poor, necessitating an evidence based treatment strategy that provides the best outcomes for individual patients. This paper summarises the results of the recently published Cochrane review on interventions in malignant pleural effusions.
AB - Optimal management of symptomatic malignant pleural effusions remains an important issue as it affects a significant number of patients each year internationally. The overall survival remains poor, necessitating an evidence based treatment strategy that provides the best outcomes for individual patients. This paper summarises the results of the recently published Cochrane review on interventions in malignant pleural effusions.
U2 - 10.1136/thoraxjnl-2016-208989
DO - 10.1136/thoraxjnl-2016-208989
M3 - Journal article
VL - 71
SP - 964
EP - 966
JO - Thorax
JF - Thorax
SN - 0040-6376
IS - 10
ER -